You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 162 No. 1, January 14, 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (118)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Bacterial Infections
 •Dialysis
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Changing Patient Characteristics and the Effect on Mortality in Endocarditis

Christopher H. Cabell, MD; James G. Jollis, MD; Gail E. Peterson, MD; G. Ralph Corey, MD; Deverick J. Anderson, MD; Daniel J. Sexton, MD; Christopher W. Woods, MD; L. Barth Reller, MD; Thomas Ryan, MD; Vance G. Fowler, Jr, MD, MHS

Arch Intern Med. 2002;162:90-94.

Background  Limited data exist on recent demographic and microbiological changes in infective endocarditis (IE) and the impact of these changes on patient survival.

Methods  Data were collected from all patients with definite or possible IE at Duke University Medical Center, Durham, NC, from 1993 to 1999. Logistic regression analysis was used to identify demographic and microbiological changes that occurred in patients with IE over the study period. The impact of these changes on survival was evaluated using Cox proportional hazards modeling.

Results  Among the 329 study patients, rates of hemodialysis dependence, immunosuppression, and Staphylococcus aureus infection increased during the study period (P= .04, P= .008, and P<.001, respectively), while rates of infection due to viridans group streptococci decreased (P= .007). Hemodialysis was independently associated with S aureus infection (odds ratio, 3.1; 95% confidence interval, 1.6-5.9). Patients with S aureus IE had a higher 1-year mortality rate (43.9% vs 32.5%; P= .04) that persisted after adjustment for other illness severity characteristics (hazard ratio, 1.5; 95% confidence interval, 1.03-2.3).

Conclusions  The demographic and microbiological characteristics of IE at our institution have changed over the past decade in ways that suggest a link between medical practice and IE characteristics. Staphylococcus aureus has emerged as a dominant cause of IE, and is an independent predictor of mortality. These findings identify clinical settings that may warrant closer surveillance and more aggressive measures in the identification and prevention of endocarditis.


From the Department of Medicine, Duke University School of Medicine (Drs Cabell, Jollis, Peterson, Corey, Anderson, Sexton, Woods, Reller, Ryan, and Fowler), Duke Clinical Research Institute (Drs Cabell and Jollis), and Durham Veterans Administration Medical Center (Dr Peterson), Durham, NC.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Archives of Internal Medicine Reader's Choice: Continuing Medical Education
Arch Intern Med. 2002;162(1):111.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC)
Endorsed by the European Society of Clinical Micro et al.
Eur Heart J 2009;30:2369-2413.
FULL TEXT  

Health Care-Associated Native Valve Endocarditis: Importance of Non-nosocomial Acquisition
Benito et al.
ANN INTERN MED 2009;150:586-594.
ABSTRACT | FULL TEXT  

Continuous versus Intermittent Infusion of Oxacillin for Treatment of Infective Endocarditis Caused by Methicillin-Susceptible Staphylococcus aureus
Hughes et al.
Antimicrob. Agents Chemother. 2009;53:2014-2019.
ABSTRACT | FULL TEXT  

The timing of surgery influences mortality and morbidity in adults with severe complicated infective endocarditis: a propensity analysis
Thuny et al.
Eur Heart J 2009;0:ehp089v1-ehp089.
ABSTRACT | FULL TEXT  

Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st Century: The International Collaboration on Endocarditis-Prospective Cohort Study
Murdoch et al.
Arch Intern Med 2009;169:463-473.
ABSTRACT | FULL TEXT  

Infective endocarditis in elderly patients: clinical characteristics and outcome
Remadi et al.
Eur. J. Cardiothorac. Surg. 2009;35:123-129.
ABSTRACT | FULL TEXT  

Infective endocarditis in children: native valve preservation is frequently possible despite advanced clinical disease
Hickey et al.
Eur. J. Cardiothorac. Surg. 2009;35:130-135.
ABSTRACT | FULL TEXT  

Long-term Outcome of Infective Endocarditis in Non-Intravenous Drug Users
Martinez-Selles et al.
Mayo Clin Proc. 2008;83:1213-1217.
ABSTRACT | FULL TEXT  

Non-HACEK Gram-Negative Bacillus Endocarditis
Morpeth et al.
ANN INTERN MED 2007;147:829-835.
ABSTRACT | FULL TEXT  

Infective endocarditis in chronic haemodialysis patients: an increasing clinical challenge
Nucifora et al.
Eur Heart J 2007;28:2307-2312.
ABSTRACT | FULL TEXT  

Efficacy of Telavancin in the Treatment of Experimental Endocarditis Due to Glycopeptide-Intermediate Staphylococcus aureus
Miro et al.
Antimicrob. Agents Chemother. 2007;51:2373-2377.
ABSTRACT | FULL TEXT  

Predictors of Death and Impact of Surgery in Staphylococcus aureus Infective Endocarditis
Remadi et al.
Ann. Thorac. Surg. 2007;83:1295-1302.
ABSTRACT | FULL TEXT  

Bacteraemia following debanding and gold chain adjustment
Lucas et al.
Eur J Orthod 2007;29:161-165.
ABSTRACT | FULL TEXT  

Contemporary Clinical Profile and Outcome of Prosthetic Valve Endocarditis
Wang et al.
JAMA 2007;297:1354-1361.
ABSTRACT | FULL TEXT  

Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort study
Hill et al.
Eur Heart J 2007;28:196-203.
ABSTRACT | FULL TEXT  

Diabetes mellitus and infective endocarditis: the insulin factor in patient morbidity and mortality
Duval et al.
Eur Heart J 2007;28:59-64.
ABSTRACT | FULL TEXT  

Epidemiology and antibiotic treatment of infective endocarditis: an update.
Hoen
Heart 2006;92:1694-1700.
FULL TEXT  

Infective endocarditis in a Finnish teaching hospital: a study on 326 episodes treated during 1980-2004
Heiro et al.
Heart 2006;92:1457-1462.
ABSTRACT | FULL TEXT  

Infective endocarditis
Beynon et al.
BMJ 2006;333:334-339.
FULL TEXT  

Mortality risk factors in chronic haemodialysis patients with infective endocarditis
Nori et al.
Nephrol Dial Transplant 2006;21:2184-2190.
ABSTRACT | FULL TEXT  

The role of aminoglycosides in combination with a {beta}-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials
Falagas et al.
J Antimicrob Chemother 2006;57:639-647.
ABSTRACT | FULL TEXT  

Clinical features remain important for the diagnosis of infective endocarditis in the modern era
Todd et al.
QJM 2006;99:23-31.
ABSTRACT | FULL TEXT  

Endocarditis From Staphylococcus aureus--Reply
Fowler
JAMA 2005;294:2972-2973.
FULL TEXT  

Nosocomial Endocarditis in a Tertiary Hospital: An Increasing Trend in Native Valve Cases
Martin-Davila et al.
Chest 2005;128:772-779.
ABSTRACT | FULL TEXT  

Risk of Embolism and Death in Infective Endocarditis: Prognostic Value of Echocardiography: A Prospective Multicenter Study
Thuny et al.
Circulation 2005;112:69-75.
ABSTRACT | FULL TEXT  

Comparison of clinical and morphological characteristics of Staphylococcus aureus endocarditis with endocarditis caused by other pathogens
Nadji et al.
Heart 2005;91:932-937.
ABSTRACT | FULL TEXT  

Staphylococcus aureus Endocarditis: A Consequence of Medical Progress
Fowler et al.
JAMA 2005;293:3012-3021.
ABSTRACT | FULL TEXT  

Temporal Trends in Infective Endocarditis: A Population-Based Study in Olmsted County, Minnesota
Tleyjeh et al.
JAMA 2005;293:3022-3028.
ABSTRACT | FULL TEXT  

Infective Endocarditis: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Statement for Healthcare Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: Endorsed by the Infectious Diseases Society of America
Baddour et al.
Circulation 2005;111:e394-e434.
ABSTRACT | FULL TEXT  

Impact of High-Inoculum Staphylococcus aureus on the Activities of Nafcillin, Vancomycin, Linezolid, and Daptomycin, Alone and in Combination with Gentamicin, in an In Vitro Pharmacodynamic Model
LaPlante and Rybak
Antimicrob. Agents Chemother. 2004;48:4665-4672.
ABSTRACT | FULL TEXT  

Infective endocarditis: a frequent disease in dialysis patients
Hoen
Nephrol Dial Transplant 2004;19:1360-1362.
FULL TEXT  

Diagnostic criteria and problems in infective endocarditis
Prendergast
Heart 2004;90:611-613.
FULL TEXT  

Endocarditis diagnosed as multilobar, community acquired pneumonia
Muntan and Haydel
Emerg. Med. J. 2004;21:244-245.
FULL TEXT  

Evaluating and Optimizing Outcomes of Surgery for Endocarditis
Durack
JAMA 2003;290:3250-3251.
FULL TEXT  

Clinical Identifiers of Complicated Staphylococcus aureus Bacteremia
Fowler et al.
Arch Intern Med 2003;163:2066-2072.
ABSTRACT | FULL TEXT  

Diagnosis of infective endocarditis
Prendergast
BMJ 2002;325:845-846.
FULL TEXT  

Recent Trends in Endocarditis
JWatch Infect. Diseases 2002;2002:4-4.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.